StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $13.19 | $13.22 | +0.23% | 0.1M |
| 05-12 | $13.22 | $13.37 | +1.13% | 0.0M |
| 05-13 | $13.26 | $13.53 | +2.04% | 0.0M |
| 05-14 | $14.50 | $15.59 | +7.52% | 0.2M |
| 05-15 | $15.45 | $15.63 | +1.17% | 0.3M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
No sell-side coverage available for SI.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Fundamentals not available for SI.
No fundamental metrics available yet for this ticker — common for ETFs, foreign issuers without US listing depth, very recent IPOs, or thinly-traded OTC names. The Financials tab pulls from SEC EDGAR directly and may still have data.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $16.71M | $47.32M | $32.90M | $21.14M |
Operating Income | $-8.98M | $-26.30M | $-17.80M | $-10.16M |
Net Income | $-8.38M | $-40.36M | $-32.59M | $-19.20M |
EPS (Diluted) | $-0.41 | $-4.65 | $-7.00 | $-232.13 |
Total Assets | $160.36M | $169.91M | $177.76M | $77.83M |
Total Liabilities | $27.34M | $29.16M | $29.93M | $29.33M |
Cash & Equivalents | $11.49M | $26.87M | $54.93M | $27.05M |
Free Cash Flow OCF − CapEx | $-15.09M | $-36.02M | $-24.95M | $-13.59M |
Shares Outstanding | 20.70M | 20.62M | 20.58M | 2.84M |
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.